These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22180352)

  • 1. Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer's Disease.
    Xiong Z; Hongmei Z; Lu S; Yu L
    Pharmacol Rep; 2011; 63(5):1101-8. PubMed ID: 22180352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin activates Wnt/β-catenin signaling pathway through inhibiting the activity of GSK-3β in APPswe transfected SY5Y cells.
    Zhang X; Yin WK; Shi XD; Li Y
    Eur J Pharm Sci; 2011 Apr; 42(5):540-6. PubMed ID: 21352912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway.
    Huang HC; Tang D; Xu K; Jiang ZF
    J Recept Signal Transduct Res; 2014 Feb; 34(1):26-37. PubMed ID: 24188406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dieckol Ameliorates Aβ Production via PI3K/Akt/GSK-3β Regulated APP Processing in SweAPP N2a Cell.
    Yoon JH; Lee N; Youn K; Jo MR; Kim HR; Lee DS; Ho CT; Jun M
    Mar Drugs; 2021 Mar; 19(3):. PubMed ID: 33804171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin-mediated neuroprotection against amyloid-β-induced mitochondrial dysfunction involves the inhibition of GSK-3β.
    Huang HC; Xu K; Jiang ZF
    J Alzheimers Dis; 2012; 32(4):981-96. PubMed ID: 22886017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin Decreases Hyperphosphorylation of Tau by Down-Regulating Caveolin-1/GSK-3β in N2a/APP695swe Cells and APP/PS1 Double Transgenic Alzheimer's Disease Mice.
    Sun J; Zhang X; Wang C; Teng Z; Li Y
    Am J Chin Med; 2017; 45(8):1667-1682. PubMed ID: 29132216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of glycogen synthase kinase 3 in Alzheimer's disease.
    Cai Z; Zhao Y; Zhao B
    Curr Alzheimer Res; 2012 Sep; 9(7):864-79. PubMed ID: 22272620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta.
    Cedazo-Mínguez A; Popescu BO; Blanco-Millán JM; Akterin S; Pei JJ; Winblad B; Cowburn RF
    J Neurochem; 2003 Dec; 87(5):1152-64. PubMed ID: 14622095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease beta-amyloid production.
    Rezai-Zadeh K; Douglas Shytle R; Bai Y; Tian J; Hou H; Mori T; Zeng J; Obregon D; Town T; Tan J
    J Cell Mol Med; 2009 Mar; 13(3):574-88. PubMed ID: 18410522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huannao Yicong decoction ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by interfering with neurotoxic interaction of Aβ-tau.
    Zhang H; Chen W; Li Z; Huang Q; Wen J; Chang S; Pei H; Ma L; Li H
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116985. PubMed ID: 37532075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of amyloid-β through AMPK activation by inhibitors of GSK-3β in SH-SY5Y and SH-SY5Y-AβPP695 cells.
    Cai Z; Li B; Li K; Zhao B
    J Alzheimers Dis; 2012; 29(1):89-98. PubMed ID: 22214783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice.
    Tan X; Liang Z; Li Y; Zhi Y; Yi L; Bai S; Forest KH; Nichols RA; Dong Y; Li QX
    Behav Brain Res; 2021 Feb; 398():112968. PubMed ID: 33069740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.
    Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM
    J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
    Koh SH; Noh MY; Kim SH
    Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
    J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
    Cai Z; Wang C; He W; Chen Y
    Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.
    Phiel CJ; Wilson CA; Lee VM; Klein PS
    Nature; 2003 May; 423(6938):435-9. PubMed ID: 12761548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of new Presenilin-1 phosphosites: implication for γ-secretase activity and Aβ production.
    Matz A; Halamoda-Kenzaoui B; Hamelin R; Mosser S; Alattia JR; Dimitrov M; Moniatte M; Fraering PC
    J Neurochem; 2015 May; 133(3):409-21. PubMed ID: 25458374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.